Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193


Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group.

Msellati P, Meda N, Leroy V, Likikouët R, Van de Perre P, Cartoux M, Bonard D, Ouangre A, Combe P, Gautier-Charpentier L, Sylla-Koko F, Lassalle R, Dosso M, Welffens-Ekra C, Dabis F, Mandelbrot L.

Sex Transm Infect. 1999 Dec;75(6):420-5.


15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery.

Mandelbrot L, Msellati P, Meda N, Leroy V, Likikouët R, Van de Perre P, Dequae-Merchadoux L, Sylla-Koko F, Ouangre A, Ouassa T, Ramon R, Gautier-Charpentier L, Cartoux M, Dosso M, Dabis F, Welffens-Ekra C; ANRS 049 Ditrame Study Group.

Sex Transm Infect. 2002 Aug;78(4):267-70.


6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, Leroy V, Simonon A, Cartoux M, Combe P, Ouangré A, Ramon R, Ky-Zerbo O, Montcho C, Salamon R, Rouzioux C, Van de Perre P, Mandelbrot L.

Lancet. 1999 Mar 6;353(9155):786-92.


Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa.

Meda N, Leroy V, Viho I, Msellati P, Yaro S, Mandelbrot L, Montcho C, Manigart O, Dabis F; DITRAME-ANRS 049 Study Group.

AIDS. 2002 Nov 22;16(17):2323-8.


Acceptability of interventions to reduce mother-to-child transmission of HIV-1 in west Africa.

Cartoux M, Msellati P, Rouamba O, Coulibaly D, Meda N, Blibolo D, Mandelbrot L, Van de Perre P, Dabis F.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):290-2.


Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa.

Leroy V, Karon JM, Alioum A, Ekpini ER, van de Perre P, Greenberg AE, Msellati P, Hudgens M, Dabis F, Wiktor SZ; West Africa PMTCT Study Group.

AIDS. 2003 Jul 4;17(10):1493-501.


Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.

TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F.

AIDS. 2009 Apr 27;23(7):825-33. doi: 10.1097/QAD.0b013e32832949d5.


Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.


Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa.

Leroy V, Karon JM, Alioum A, Ekpini ER, Meda N, Greenberg AE, Msellati P, Hudgens M, Dabis F, Wiktor SZ; West Africa PMTCT Study Group.

AIDS. 2002 Mar 8;16(4):631-41.


Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire, 1998-99.

Msellati P, Hingst G, Kaba F, Viho I, Welffens-Ekra C, Dabis F.

Bull World Health Organ. 2001;79(7):641-7.


Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.

Limpongsanurak S, Thaithumyanon P, Chaithongwongwatthana S, Thisyakorn U, Ruxrungtham K, Kongsin P, Tarounotai U, Chantheptaewan N, Triratwerapong T, Ubolyam S, Phanuphak P, Virutamasen P, Hanwanich M, Hawanon P, Chulasugondha P.

J Med Assoc Thai. 2001 Jun;84 Suppl 1:S338-45.


[Refusal of prenatal HIV-testing: a case study in Abidjan (Côte d'Ivoire)].

Desgrées du Loû A, Brou H, Djohan G, Tijou-Traoré A; Groupe Ditrame Plus.

Sante. 2007 Jul-Sep;17(3):133-41. doi: 10.1684/san.2007.0081. French.


18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.

Harambat J, Fassinou P, Becquet R, Touré P, Rouet F, Dabis F, Msellati P, Blanche S, Timité-Konan M, Salamon R, Leroy V; ANRS 1201/1202 Ditrame Plus Study Group.

BMC Public Health. 2008 May 20;8:169. doi: 10.1186/1471-2458-8-169.


HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire.

Jamieson DJ, Sibailly TS, Sadek R, Roels TH, Ekpini ER, Boni-Ouattara E, Karon JM, Nkengasong J, Greenberg AE, Wiktor SZ.

J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):430-6.


Anaemia during pregnancy in Burkina Faso, west Africa, 1995-96: prevalence and associated factors. DITRAME Study Group.

Meda N, Mandelbrot L, Cartoux M, Dao B, Ouangré A, Dabis F.

Bull World Health Organ. 1999;77(11):916-22.


Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire.

Painter TM, Diaby KL, Matia DM, Lin LS, Sibailly TS, Kouassims MK, Ekpini ER, Roels TH, Wiktor SZ.

Int J STD AIDS. 2005 Mar;16(3):237-42.


A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission.

Taha TE, Brown ER, Hoffman IF, Fawzi W, Read JS, Sinkala M, Martinson FE, Kafulafula G, Msamanga G, Emel L, Adeniyi-Jones S, Goldenberg R.

AIDS. 2006 Jun 12;20(9):1313-21.


[Attitudes and behavior of pregnant women towards HIV screening in Abidjan (Ivory Coast) in 1995 and 1996].

Coulibaly D, Msellati P, Dedy S, Welffens-Ekra C, Dabis F.

Sante. 1998 May-Jun;8(3):234-8. French. Erratum in: Sante 1998 Jul-Aug;8(4):302.

Supplemental Content

Support Center